-
Subject Areas on Research
-
A comparison of the fine saccharide-binding specificity of Dioclea grandiflora lectin and concanavalin A.
-
Another step towards xenotransplantation.
-
Antigen expression in xenotransplantation: how low must it go?
-
Biophysical characteristics of anti-Gal(alpha)1-3Gal IgM binding to cell surfaces: implications for xenotransplantation.
-
Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection.
-
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.
-
Characterization of xenoreactive natural antibodies: interactions with carbohydrate determinants.
-
Diagnosis of Life-Threatening Alpha-Gal Food Allergy Appears to Be Patient Driven.
-
Differential recognition by proteins of alpha-galactosyl residues on endothelial cell surfaces.
-
Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation.
-
Distribution of, and immune response to, chicken anti-alpha Gal immunoglobulin Y antibodies in wild-type and alpha Gal knockout mice.
-
Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia.
-
Evidence for polyreactive xenoreactive antibodies in the repertoire of human anti-swine antibodies: the 'next' humoral barrier to xenotransplantation?
-
Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose.
-
Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation.
-
Galactose-α-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children.
-
Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter.
-
Identification and characterization of a galactosyl peptide mimetic. Implications for use in removing xenoreactive anti-A Gal antibodies.
-
Identification and characterization of a peptide mimeotope of galactose alpha 1,3 galactose.
-
Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.
-
Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor.
-
Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
-
Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies.
-
Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies.
-
Molecular barriers to xenotransplantation.
-
Relative purity of thrombin-based hemostatic agents used in surgery.
-
Role of the microvillus in the absorption of disaccharides.
-
Sensitization with xenogeneic tissues alters the heavy chain repertoire of human anti-Galalpha1-3Gal antibodies.
-
Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development.
-
Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands.
-
Structural adaptations that modulate monosaccharide, disaccharide, and trisaccharide specificities in periplasmic maltose-binding proteins.
-
The crystal structure of a thermophilic glucose binding protein reveals adaptations that interconvert mono and di-saccharide binding sites.
-
The footprint of antibody bound to pig cells: evidence of complex surface topology.
-
The humoral immune response in humans following ex vivo perfusion of porcine livers.
-
The potential of xenotransplants.
-
The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.
-
The role of antibodies and von Willebrand factor in discordant pulmonary xenotransplantation.
-
The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.
-
Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal.